CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 197 enrolled
Drug / intervention
BAL fluid sampling +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02838407
NCT02838407N/ACompleted
CompareCT.gov

Identification and Characterization of Bacteria in the Lower Airways of Children Aged ≥ 6 Months to < 6 Years With Suspected Lower Respiratory Tract Infections (LRTI) in Spain.

GlaxoSmithKline·interventional·Posted Jul 20, 2016·Updated Oct 4, 2019

In Brief

A clinical study evaluating BAL fluid sampling and Nasopharyngeal swab sampling for Infections, Streptococcal. Completed, enrolled 197 participants across 7 sites.

Detailed Summary

The purpose of this study is to identify and characterise bacteria present in the lower airways of children with suspected chronic LRTIs and for whom bronchoalveolar lavage (BAL) is indicated by the clinician.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfections, Streptococcal
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 20, 2016
Enrollment StartSep 23, 2013
Primary CompletionSep 23, 2015
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 10.0 years ago

Interventions

BAL fluid samplingother

Following routine BAL procedures at the hospital, collection of BAL fluid samples: at least 2 mL, at Day 0.

Nasopharyngeal swab samplingother

1 swab, Day 0